ArticleParkinson's disease2026

The Efficacy and Safety of Monoclonal Antibodies That Target Alpha-Synuclein in Parkinson's Disease: A Systematic Review.

Daniel Coles et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.